Impaired type IIFN-induced Jak/STAT signaling in FA-C cells and abnormal CD4+ Th cell subsets in Fancc-/- mice

被引:22
作者
Fagerlie, SR
Koretsky, T
Torok-Storb, B
Bagby, GC
机构
[1] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA
[2] Oregon Hlth Sci Univ, Inst Canc, Portland, OR 97201 USA
[3] Oregon Hlth & Sci Univ, Dept Med, Div Hematol & Med Oncol, Portland, OR 97201 USA
[4] Portland Vet Affairs Med Ctr, Portland, OR 97201 USA
关键词
D O I
10.4049/jimmunol.173.6.3863
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The Fanconi anemia (FA) group C protein, FANCC, interacts with STAT1 following stimulation with IFN-gamma and is required for proper docking of STAT1 at the IFN-gamma receptor a-chain (IFN-gammaRa, IFN-gammaR1). Consequently, loss of a functional FANCC results in decreased activation of STATI following IFN-gamma stimulation. Because type I IFN receptors influence the function of type II receptors, and vice versa, we conducted experiments designed to determine whether type I IFN-induced activation of other STAT proteins is compromised in FA-C cells and found that activation of STAT 1, 3, and 5 is diminished in type I IFN-stimulated cells bearing Fance -inactivating mutations. We also determined that the reduced activation of STATs was accompanied by significant reduction of type I IFN-induced tyrosine kinase 2 and Jak1 phosphorylation. Because tyrosine kinase 2 plays a role in differentiation of Th cells, we quantified cytokine secretion from CD4(+) cells and in vitro generated CD4(+) Th cell subsets from splenocytes of Fancc null mice to that of heterozygous mice and discovered reduced CD4(+) IFN-gamma secretion in the Fancc(-/-) mouse, indicating impaired Th1 differentiation. We suggest that Fancc mutations result in a subtle immunological defect owing to the failure of FANCC to normally support Jak/STAT signaling.
引用
收藏
页码:3863 / 3870
页数:8
相关论文
共 78 条
[31]   Biallelic inactivation of BRCA2 in Fanconi anemia [J].
Howlett, NG ;
Taniguchi, T ;
Olson, S ;
Cox, B ;
Waisfisz, Q ;
de Die-Smulders, C ;
Persky, N ;
Grompe, M ;
Joenje, H ;
Pals, G ;
Ikeda, H ;
Fox, EA ;
D'Andrea, AD .
SCIENCE, 2002, 297 (5581) :606-609
[32]  
Infante-Duarte C, 1999, SPRINGER SEMIN IMMUN, V21, P317, DOI 10.1007/s002810050070
[33]   Immortalization of four new Fanconi anemia fibroblast cell lines by an improved procedure [J].
Jakobs, PM ;
Sahaayaruban, P ;
Saito, H ;
Reifsteck, C ;
Olson, S ;
Joenje, H ;
Moses, RE ;
Grompe, M .
SOMATIC CELL AND MOLECULAR GENETICS, 1996, 22 (02) :151-157
[34]   FANCONIS ANEMIA - TUMOR-LIKE WARTS, HYPER-PIGMENTATION ASSOCIATED WITH DERANGED KERATINOCYTES, AND DEPRESSED CELL-MEDIATED-IMMUNITY [J].
JOHANSSON, E ;
NIEMI, KM ;
SIIMES, M ;
PYRHONEN, S .
ARCHIVES OF DERMATOLOGY, 1982, 118 (04) :249-252
[35]   Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice [J].
Kaplan, DH ;
Shankaran, V ;
Dighe, AS ;
Stockert, E ;
Aguet, M ;
Old, LJ ;
Schreiber, RD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (13) :7556-7561
[36]  
KAPLAN MJ, 1985, LARYNGOSCOPE, V95, P771
[37]   Partial impairment of cytokine responses in Tyk2-deficient mice [J].
Karaghiosoff, M ;
Neubauer, H ;
Lassnig, C ;
Kovarik, P ;
Schindler, H ;
Pircher, H ;
McCoy, B ;
Bogdan, C ;
Decker, T ;
Brem, G ;
Pfeffer, K ;
Müller, M .
IMMUNITY, 2000, 13 (04) :549-560
[38]   Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection [J].
Kelly, JM ;
Darcy, PK ;
Markby, JL ;
Godfrey, DI ;
Takedo, K ;
Yagita, H ;
Smyth, MJ .
NATURE IMMUNOLOGY, 2002, 3 (01) :83-90
[39]  
Kerttula TO, 1999, SCAND J IMMUNOL, V49, P197
[40]   Structure-function study of the extracellular domain of the human type I interferon receptor (IFNAR)-1 subunit [J].
Kumaran, J ;
Colamonici, OR ;
Fish, EN .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2000, 20 (05) :479-485